Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Different NF-κB activation characteristics of human respiratory syncytial virus subgroups A and B.

Wu W, Macdonald A, Hiscox JA, Barr JN.

Microb Pathog. 2012 Mar;52(3):184-91. doi: 10.1016/j.micpath.2011.12.006. Epub 2011 Dec 28.

PMID:
22212641
2.

Subgroup prevalence and genotype circulation patterns of human respiratory syncytial virus in Belgium during ten successive epidemic seasons.

Zlateva KT, Vijgen L, Dekeersmaeker N, Naranjo C, Van Ranst M.

J Clin Microbiol. 2007 Sep;45(9):3022-30. Epub 2007 Jul 3.

3.

Novel clinical features of recurrent human respiratory syncytial virus infections.

Yui I, Fujino M, Sawada A, Nakayama T.

J Med Virol. 2014 Sep;86(9):1629-38. doi: 10.1002/jmv.23809. Epub 2013 Oct 25.

4.

Pathogenesis, Humoral Immune Responses, and Transmission between Cohoused Animals in a Ferret Model of Human Respiratory Syncytial Virus Infection.

Chan KF, Carolan LA, Druce J, Chappell K, Watterson D, Young P, Korenkov D, Subbarao K, Barr IG, Laurie KL, Reading PC.

J Virol. 2018 Jan 30;92(4). pii: e01322-17. doi: 10.1128/JVI.01322-17. Print 2018 Feb 15.

5.

Human Respiratory Syncytial Virus: Role of Innate Immunity in Clearance and Disease Progression.

Farrag MA, Almajhdi FN.

Viral Immunol. 2016 Jan-Feb;29(1):11-26. doi: 10.1089/vim.2015.0098. Epub 2015 Dec 17. Review.

PMID:
26679242
6.

Evaluation of protective efficacy of respiratory syncytial virus vaccine against A and B subgroup human isolates in Korea.

Jang JE, Lee JB, Kim KH, Park SM, Shim BS, Cheon IS, Song MK, Chang J.

PLoS One. 2011;6(9):e23797. doi: 10.1371/journal.pone.0023797. Epub 2011 Sep 7.

7.

Prevalence and genetic characterization of respiratory syncytial virus (RSV) in hospitalized children in Korea.

Baek YH, Choi EH, Song MS, Pascua PN, Kwon HI, Park SJ, Lee JH, Woo SI, Ahn BH, Han HS, Hahn YS, Shin KS, Jang HL, Kim SY, Choi YK.

Arch Virol. 2012 Jun;157(6):1039-50. doi: 10.1007/s00705-012-1267-1. Epub 2012 Mar 9.

PMID:
22402914
8.

Contribution of Fcγ receptors to human respiratory syncytial virus pathogenesis and the impairment of T-cell activation by dendritic cells.

Gómez RS, Ramirez BA, Céspedes PF, Cautivo KM, Riquelme SA, Prado CE, González PA, Kalergis AM.

Immunology. 2016 Jan;147(1):55-72. doi: 10.1111/imm.12541. Epub 2015 Nov 6.

9.

Circulation patterns of genetically distinct group A and B strains of human respiratory syncytial virus in a community.

Peret TC, Hall CB, Schnabel KC, Golub JA, Anderson LJ.

J Gen Virol. 1998 Sep;79 ( Pt 9):2221-9.

PMID:
9747732
11.

Genetic variability in the G protein gene of human respiratory syncytial virus isolated from the Campinas metropolitan region, Brazil.

da Silva LH, Spilki FR, Riccetto AG, de Almeida RS, Baracat EC, Arns CW.

J Med Virol. 2008 Sep;80(9):1653-60. doi: 10.1002/jmv.21249.

PMID:
18649326
12.

Molecular characterization of human respiratory syncytial virus subtype B: a novel genotype of subtype B circulating in China.

Ren L, Xiao Q, Zhou L, Xia Q, Liu E.

J Med Virol. 2015 Jan;87(1):1-9. doi: 10.1002/jmv.23960. Epub 2014 Jun 9.

PMID:
24910250
13.

High frequency of repeated infections due to emerging genotypes of human respiratory syncytial viruses among children during eight successive epidemic seasons in Japan.

Yamaguchi M, Sano Y, Dapat IC, Saito R, Suzuki Y, Kumaki A, Shobugawa Y, Dapat C, Uchiyama M, Suzuki H.

J Clin Microbiol. 2011 Mar;49(3):1034-40. doi: 10.1128/JCM.02132-10. Epub 2010 Dec 22.

14.

Impaired immune response to vaccination against infection with human respiratory syncytial virus at advanced age.

Guichelaar T, Hoeboer J, Widjojoatmodjo MN, Reemers SS, van Els CA, Otten R, van Remmerden Y, Boes J, Luytjes W.

J Virol. 2014 Sep 1;88(17):9744-50. doi: 10.1128/JVI.01101-14. Epub 2014 Jun 11.

15.

Molecular epidemiology and molecular characterization of respiratory syncytial viruses at a tertiary care university hospital in Catalonia (Spain) during the 2013-2014 season.

Gimferrer L, Campins M, Codina MG, Martín Mdel C, Fuentes F, Esperalba J, Bruguera A, Vilca LM, Armadans L, Pumarola T, Antón A.

J Clin Virol. 2015 May;66:27-32. doi: 10.1016/j.jcv.2015.02.018. Epub 2015 Feb 26.

PMID:
25866332
16.

Measurement of antibody against contemporary virus lineages of human respiratory syncytial virus sub-group A in infants and their mothers.

McGill A, Greensill J, Craft AW, Fenwick F, Toms GL.

J Clin Virol. 2004 May;30(1):73-80.

PMID:
15072758
17.

Recombinant subgroup B human respiratory syncytial virus expressing enhanced green fluorescent protein efficiently replicates in primary human cells and is virulent in cotton rats.

Lemon K, Nguyen DT, Ludlow M, Rennick LJ, Yüksel S, van Amerongen G, McQuaid S, Rima BK, de Swart RL, Duprex WP.

J Virol. 2015 Mar;89(5):2849-56. doi: 10.1128/JVI.03587-14. Epub 2014 Dec 24.

18.

Rapid replacement of human respiratory syncytial virus A with the ON1 genotype having 72 nucleotide duplication in G gene.

Kim YJ, Kim DW, Lee WJ, Yun MR, Lee HY, Lee HS, Jung HD, Kim K.

Infect Genet Evol. 2014 Aug;26:103-12. doi: 10.1016/j.meegid.2014.05.007. Epub 2014 May 10.

PMID:
24820343
19.

Molecular epidemiology of human respiratory syncytial virus over three consecutive seasons in Latvia.

Balmaks R, Ribakova I, Gardovska D, Kazaks A.

J Med Virol. 2014 Nov;86(11):1971-82. doi: 10.1002/jmv.23855. Epub 2013 Dec 2.

PMID:
24301088
20.

Transmission of Human Respiratory Syncytial Virus in the Immunocompromised Ferret Model.

de Waal L, Smits SL, Veldhuis Kroeze EJB, van Amerongen G, Pohl MO, Osterhaus ADME, Stittelaar KJ.

Viruses. 2018 Jan 2;10(1). pii: E18. doi: 10.3390/v10010018.

Supplemental Content

Support Center